Medical/Pharmaceuticals
Humavant® 100% Human Milk-Based Fortifiers Helping Premature Infants in Australia Grow and Develop
Human Milk-Based Nutrition Is Clinically Demonstrated to Improve Health Outcomes in Very Low Birth Weight Babies Compared to Cow Milk-Based Products ADELAIDE, Australia, Oct. 21, 2024 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional ...
2024-10-21 04:05
2396
Hong Kong Breast Cancer Foundation "Pink Walk 2024" Charity Walk Concluded Successfully
Nearly 2,000 Pink Walkers gathered at The Peak Walk for Breast Health, Together We Can HONG KONG, Oct. 20, 2024 /PRNewswire/ -- The signature annual charity walk, "Pink Walk 2024", organised by Hong Kong Breast Cancer Foundation (HKBCF), was successfully held today at The Peak,Hong Kong Island. ...
2024-10-20 17:23
2974
Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions
MamaLift ensures personalized care tailored to each woman's journey through motherhood, empowering them to manage stress, embrace joy, and reduce the risk of depression and anxiety during and after pregnancy. SAN ANTONIO, Oct. 19, 2024 /PRNewswire/ -- Frost & Sullivan assessed the women's health...
2024-10-19 23:30
2976
Medeze Group Awarded Frost & Sullivan's 2024 Southeast Asia Company of the Year for Delivering Highly Innovative Stem Cell and Longevity Solutions
Medeze Group (Medeze) specializes in cutting-edge stem cell banking services, leveraging advanced cryopreservation techniques and pioneering therapies to enhance longevity and health outcomes. SAN ANTONIO, Oct. 18, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the stem cell banking a...
2024-10-18 15:00
1909
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase...
2024-10-18 14:42
2158
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country
* This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug inSouth Korea. * To date, XPOVIO® has already been included in national health insurance or reimbursement schemes inSouth Korea, the mainland of China, Australia...
2024-10-18 10:35
4004
Telix Files Form 20-F Registration Statement for Nasdaq ADS
MELBOURNE, Australia, Oct. 18, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that it has publicly filed a Form 20-F registration statement (Registration Statement) withthe United States (U.S.) Securities and Exchange Commission (SEC) relating to a pro...
2024-10-18 05:32
2616
Press Announcement: AIMed24 Announces Strategic Partnership with Frost & Sullivan
SAN ANTONIO, Oct. 17, 2024 /PRNewswire/ -- AIMed24, the premier event for artificial intelligence and healthcare innovation, is excited to announce its strategic partnership with Frost & Sullivan. This collaboration will further enhance AIMed24's mission to advance healthcare with cutting-edge AI...
2024-10-17 23:01
1929
Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M
MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended30 September 2024 (Q3 2024). Revenue update, full year guidance reaffirmed * Unaudited to...
2024-10-17 15:54
2507
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
EAST RUTHERFORD, N.J., Oct. 17, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that their stability storage business, Q1 Scientific, has opened a new cGMP facility inDurham, North Carolina, expanding its capacity for envi...
2024-10-17 15:00
2730
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Temporary marketing authorization is based on statistically significant and clinically meaningful results from the phase-III PROTECT trial ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic...
2024-10-17 14:30
3779
IND Application for a Phase Ⅲ Clinical Study of KN026 Combined with Albumin-bound Docetaxel as Neoadjuvant Treatment for Breast Cancer was Approved
SUZHOU, China, Oct. 17, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (stock code: 1093.HK) jointly announced that an application for a phase III clinical study (Study ID: KN026-004) of the anti-HER2 bispecific antibody KN026 combine...
2024-10-17 10:15
2582
Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Ulcerative Colitis Met Primary Endpoint
SAN FRANCISCO and SUZHOU, China, Oct. 17, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabo...
2024-10-17 08:00
5108
Presagen's AI fertility product Life Whisperer acquired by Astec
ADELAIDE, Australia, Oct. 17, 2024 /PRNewswire/ -- Astec, a global manufacturer of medical equipment for assisted reproduction, has acquired Presagen's fertility product Life Whisperer, a non-invasive and rapid embryo and egg (oocyte) assessment tool designed to improve pregnancy outcomes for IVF...
2024-10-17 03:11
2676
Mars announces new leadership for its Veterinary Health and Science & Diagnostics businesses
* Nefertiti Greene announced as Global President of Mars Veterinary Health * Katie Devine joining to lead Mars Science & Diagnostics * Devine brings over 25 years' experience in consumer health and pharma * Mars has been a global leader in pet care for almost 90 years, now spanning veterina...
2024-10-16 23:00
3595
Tanner Health and Healthliant Ventures Partner With Corti to Accelerate Medical Coding, Cutting Workload by 80 Percent
CARROLLTON, Ga., Oct. 16, 2024 /PRNewswire/ -- In a move set to transform healthcare operations acrossGeorgia and Alabama, Tanner Health and Healthliant Ventures have announced a strategic partnership with Corti, the trusted AI platform to healthcare systems worldwide. The collaboration is expect...
2024-10-16 21:00
2794
Frost & Sullivan grants the 2024 Global Pluripotent stem cell drug R&D Innovation Award to ZEPHYRM BIOTECHNOLOGIES
SHANGHAI, Oct. 16, 2024 /PRNewswire/ -- The 18th The Growth Innovation Leadership (GIL) Council & the 3rd New Investment Conference in 2024 was held in Shanghai from August 28 to 30, 2024. On the evening of August 28, the prestigious 2024 Global and China Awards for Growth, Innovation, and Leaders...
2024-10-16 13:35
1885
Members Health Calls for National Reform to Strengthen Healthcare and Bolster Economic Prosperity and Social Wellbeing
MELBOURNE, Australia, Oct. 16, 2024 /PRNewswire/ -- Members Health is calling for major reforms to boost health care accessibility and affordability and improve transparency of hospitals and doctors acrossAustralia as part of a landmark report released today for the not-for-profit health insuranc...
2024-10-16 06:12
1919
Cardiex Awarded $525,000 Grand Prize in NIH RADx Tech for Maternal Health Challenge
SYDNEY, Oct. 16, 2024 /PRNewswire/ -- Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the$525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge. The award re...
2024-10-16 06:00
2553
AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors
HAMILTON, ON, Oct. 16, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with Radiopharm Ventures (RV), a Joint Venture between Radiopharm Theranostics (RAD) and MD And...
2024-10-16 05:00
1459
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 323 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 294 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09